1. 1
    Glenmark Pharma shares soar 33 in a month Choice retains 'Buy' with more upside seen ☶ Brokers and Exchanges Investors Pharmaceuticals
    authored by torrobot avatar torrobot 1 month ago |
    Archive.org Archive.today Ghostarchive
    | no comments

Choice Institutional Equities has reiterated its positive stance on Glenmark Pharma following a major licensing deal between its wholly-owned subsidiary, Ichnos Glenmark Innovation (IGI) and global biopharma major AbbVie.

  1.